Title:
SYMPATHETIC NERVE ACTIVATOR AND COMPOSITION FOR SYMPATHETIC NERVE ACTIVATION
Document Type and Number:
WIPO Patent Application WO/2023/218868
Kind Code:
A1
Abstract:
This sympathetic nerve activator contains a compound represented by structural formula (1).
Inventors:
KAYAKI HIROYUKI (JP)
Application Number:
PCT/JP2023/015382
Publication Date:
November 16, 2023
Filing Date:
April 17, 2023
Export Citation:
Assignee:
MARUZEN PHARM CO LTD (JP)
International Classes:
A61K31/192; A23L33/10; A61P25/02
Domestic Patent References:
| WO2014048888A1 | 2014-04-03 |
Foreign References:
| JP2016079186A | 2016-05-16 | |||
| JP2013189442A | 2013-09-26 | |||
| JP2009023964A | 2009-02-05 |
Other References:
KIM, et al. The effects of DPP4 inhibitors on the levels of plasma catecholamines and their metabolites in patients with type 2 diabetes. Diabetes Research and Clinical Practice, 2019, vol. 156, no.107832, pp. 1-8, ISSN 0168-8227
Attorney, Agent or Firm:
ITOH, Tadashige et al. (JP)
Download PDF: